171 senior director jobs found

Our desire to make a positive impact on our patients extends to our employees and we are committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. 

Our desire to make a positive impact on our patients extends to our employees and we are committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. 

Our desire to make a positive impact on our patients extends to our employees and we are committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. 

Bristol Myers Squibb is a global biopharmaceutical company committed to creating innovative medicines for millions of patients around the world fighting serious diseases in therapeutic areas such as oncology, hematology, immunology, cardiovascular and neuroscience. At the same time, we also nurture our own team with inspiring work and challenging career options.

Established in 2006 by the merger of two 100-year-old Japanese pharmaceutical companies, Daiichi Sankyo, Inc. is headquartered in New Jersey. The organization includes U.S. commercial operations and global drug development. We offer a unique blend of an entrepreneurial environment and a collaborative culture, and the innovation that propels us forward comes from all corners of our company. At Daiichi Sankyo, good ideas don't just happen in the lab, but also in conference rooms, at desks and in the field, contributed both by individuals and groups.

Established in 2006 by the merger of two 100-year-old Japanese pharmaceutical companies, Daiichi Sankyo, Inc. is headquartered in New Jersey. The organization includes U.S. commercial operations and global drug development. We offer a unique blend of an entrepreneurial environment and a collaborative culture, and the innovation that propels us forward comes from all corners of our company. At Daiichi Sankyo, good ideas don't just happen in the lab, but also in conference rooms, at desks and in the field, contributed both by individuals and groups.

Established in 2006 by the merger of two 100-year-old Japanese pharmaceutical companies, Daiichi Sankyo, Inc. is headquartered in New Jersey. The organization includes U.S. commercial operations and global drug development. We offer a unique blend of an entrepreneurial environment and a collaborative culture, and the innovation that propels us forward comes from all corners of our company. At Daiichi Sankyo, good ideas don't just happen in the lab, but also in conference rooms, at desks and in the field, contributed both by individuals and groups.

Established in 2006 by the merger of two 100-year-old Japanese pharmaceutical companies, Daiichi Sankyo, Inc. is headquartered in New Jersey. The organization includes U.S. commercial operations and global drug development. We offer a unique blend of an entrepreneurial environment and a collaborative culture, and the innovation that propels us forward comes from all corners of our company. At Daiichi Sankyo, good ideas don't just happen in the lab, but also in conference rooms, at desks and in the field, contributed both by individuals and groups.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Bristol Myers Squibb is a global biopharmaceutical company committed to creating innovative medicines for millions of patients around the world fighting serious diseases in therapeutic areas such as oncology, hematology, immunology, cardiovascular and neuroscience. At the same time, we also nurture our own team with inspiring work and challenging career options.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

Welcome to ANI Pharmaceuticals, where we are dedicated to improving and enhancing patients' lives through the manufacturing and distribution of high-quality pharmaceutical products.

Amneal is one of the largest and fastest growing generic pharmaceutical manufacturers in the United States, with an expanding portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas. The Company also markets a portfolio of branded pharmaceutical products through its Specialty Pharma division focused principally on central nervous system disorders and parasitic infections. For more information, visit www.amneal.com.

Amneal is one of the largest and fastest growing generic pharmaceutical manufacturers in the United States, with an expanding portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas. The Company also markets a portfolio of branded pharmaceutical products through its Specialty Pharma division focused principally on central nervous system disorders and parasitic infections. For more information, visit www.amneal.com.

Working at Alexion is an experience like no other. With a focus on devastating and rare diseases, each endeavor is urgent and every day counts. You’ll have the opportunity to work on one of the most robust and exciting rare disease pipelines in the biopharmaceutical industry, which includes dozens of diverse preclinical programs across a range of therapeutic modalities. Ground-breaking innovation, life-saving therapies and a promising pipeline, all driven by a team with a shared sense of purpose and dedication – that’s Alexion. Join us to achieve the impossible and do what’s never been done before.

Janssen Research & Development, LLC., a division of Johnson & Johnson's Family of Companies is recruiting a talented Scientist to join our Small Molecule, Discovery Pharmaceutics team, which is part of the Therapeutics Development & Supply organization based at Janssen’s R&D site in Spring House, Pennsylvania. At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it. Learn more at  www.janssen.com  and follow us @JanssenGlobal. Our Discovery-Facing team is focused on providing support to the Discovery organization from Hit-to-Lead through the identification and selection of clinical assets. As an integral part of a cross-functional...

Janssen Research & Development, LLC., a division of Johnson & Johnson's Family of Companies is recruiting a talented Scientist to join our Small Molecule, Discovery Pharmaceutics team, which is part of the Therapeutics Development & Supply organization based at Janssen’s R&D site in Spring House, Pennsylvania. At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it. Learn more at  www.janssen.com  and follow us @JanssenGlobal. Our Discovery-Facing team is focused on providing support to the Discovery organization from Hit-to-Lead through the identification and selection of clinical assets. As an integral part of a cross-functional...

Supernus Pharmaceuticals wouldn't mind being a drug-maker superhero of sorts to epileptics. As a specialty pharmaceutical company, Supernus develops treatments for epilepsy and other central nervous system disorders.